MAPT and neurodegenerative disease: Among the pathological changes taking place in neurodegenerative diseases, in both humans and laboratory animals, the first symptoms are the excessive deposition of amyloid-β in the brain and neurofibrillary degeneration in the form of hyperphosphorylated Tau protein.